
Juvilet-P 750mcg/75mg Tablet
Marketer
Lewis Bioserch Pharma Pvt Ltd
Salt Composition
Methylcobalamin (750mcg) + Pregabalin (75mg)
Overview Juvilet-P 750mcg/75mg Tablet
Prenoxal 750mcg/75mg tablets are a prescription medication for neuropathic pain management. It reduces pain signals by regulating nerve cell calcium channels. This medication also safeguards nerve fibers and promotes the repair of damaged nerve cells. Prenoxal 750mcg/75mg tablets are administered orally, with or without food, ideally before sleep. Consistent daily dosing, at the same time each day, helps maintain stable drug levels. Follow your doctor's prescribed dosage and duration, as this medication can be habit-forming. If a dose is missed, take it immediately upon recollection. Complete the entire course of treatment, even if symptoms improve. Abrupt cessation should be avoided without consulting your physician. Common side effects include upper respiratory infection, increased hunger, elevated mood, trembling, vision blurring, dry mouth, lightheadedness, and drowsiness. Avoid driving or activities requiring concentration until the medication's effects are understood. Side effects are usually mild and subside over time. Weight gain is possible; regular exercise and a balanced diet can help mitigate this. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal thoughts to your doctor. Disclose all other medications currently being used, as interactions may reduce efficacy or alter the drug's action. Inform your doctor of pregnancy, pregnancy planning, or breastfeeding.
Primary Ingredients of Juvilet-P 750mcg/75mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Juvilet-P 750mcg/75mg Tablet
Managing neuropathic pain
Major Benefits of Juvilet-P 750mcg/75mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Juvilet-P 750mcg/75mg Tablet can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Juvilet-P 750mcg/75mg Tablet:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Juvilet-P 750mcg/75mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Juvilet-P 750mcg/75mg Tablet can be consumed with or without food, though consistent daily timing is recommended.
How Juvilet-P 750mcg/75mg Tablet works:
Juvilet-P 750mcg/75mg tablets contain methylcobalamin and pregabalin, working synergistically to alleviate neuropathic pain. Methylcobalamin, a vitamin B derivative, supports myelin sheath production, protecting and repairing nerve fibers. Pregabalin, an alpha-2-delta ligand, reduces pain signaling by modulating nerve cell calcium channels. This combination targets nerve damage to provide effective pain relief.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Juvilet-P 750mcg/75mg tablets and alcohol may induce pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
The use of Juvilet-P 750mcg/75mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Juvilet-P 750mcg/75mg tablets while breastfeeding is likely inadvisable. Scant available human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Juvilet-P 750mcg/75mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving while experiencing these effects.
KidneyCAUTION
Patients with kidney impairment should use Juvilet-P 750mcg/75mg tablets cautiously, as dosage modification might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Juvilet-P 750mcg/75mg tablets in patients with liver impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Juvilet-P 750mcg/75mg Tablet :
Should you forget a Juvilet-P 750mcg/75mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Juvilet-P 750mcg/75mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
